Status | Study |
Recruiting |
Study Name: Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Condition: Adult Germ Cell Tumor Childhood Extracranial Germ Cell Tumor Date: 2017-02-14 Interventions: Other: Best Practice Undergo o |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Condition: Gestational Trophoblastic Neoplasia Choriocarcinoma Date: 2016-01-20 Interventions: Drug: TRC105 Subjects will beg |
Active, not recruiting |
Study Name: Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma Condition: Choriocarcinoma Date: 2015-03-05 Interventions: Biological: TRC105 weekly i.v. |
Recruiting |
Study Name: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Germ Cell Tumor Teratoma Choriocarci Date: 2015-02-20 Interventions: Drug: paclitaxel IV |
Active, not recruiting |
Study Name: Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Condition: Choriocarcinoma FIGO Stage I Gestational Trophoblastic Tumor Date: 2012-02-14 Interventions: Biological: Dactinomycin Given |
Recruiting |
Study Name: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings Condition: Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Date: 2011-09-13 Interventions: Other: laboratory biomarker analysis |
Recruiting |
Study Name: Clinical Database and Biobank of Patients With Gynecologic Neoplasms Condition: Cervical Cancer Ovarian Cancer Endometrial Cancer Date: 2010-12-28 |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Active, not recruiting |
Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condition: Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Date: 2010-03-03 Interventions: Procedure: Cognitive Assessment |